Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.59
+0.47 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
55
56
Next >
Earnings Scheduled For July 29, 2022
July 29, 2022
Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million.
Via
Benzinga
$100 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
July 28, 2022
AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 6.99% on an annualized basis producing an average annual return of 17.21%. Currently, AstraZeneca has a market...
Via
Benzinga
AstraZeneca Eyes A Trio Of Drug Approvals And Maybe A Breakout
July 25, 2022
The company is asking for approval of three drugs in Europe and the U.S.
Via
Investor's Business Daily
FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review
July 25, 2022
The United States Food and Drug Administration (FDA) has accepted to review the supplemental Biologics License Application (sBLA) of AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo’s lead asset ENHERTU...
Via
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low metastatic breast cancer
July 25, 2022
From
AstraZeneca
Via
Business Wire
U.S. Stock Futures Higher; Crude Oil Rises 1%
July 25, 2022
Pre-open movers
Via
Benzinga
Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments
July 25, 2022
Via
Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
July 24, 2022
Big tech earnings will flow in thick and fast in the upcoming week, providing more clarity on how supply chain disruptions and the macroeconomic malaise have impacted these companies.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
This Is What Whales Are Betting On AstraZeneca
July 20, 2022
Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer Study
July 19, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting
July 19, 2022
Via
Benzinga
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
July 18, 2022
Via
Benzinga
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by...
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
July 15, 2022
AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 5.58% on an annualized basis producing an average annual return of 14.99%. Currently, AstraZeneca has a market...
Via
Benzinga
HUTCHMED Highlights SAVANNAH Trial Data Of Savolitinib Combo In Lung Cancer Setting
July 13, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program
July 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review
July 13, 2022
Via
Benzinga
Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13
July 13, 2022
CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge
Via
Benzinga
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
July 13, 2022
Via
Benzinga
Stocks To Watch: Baidu, UnitedHealth Lead 5 Near Buy Points
July 09, 2022
Here's a diverse group of stocks showing strength. But still use caution.
Via
Investor's Business Daily
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.
Via
InvestorPlace
Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion?
July 07, 2022
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
Via
Investor's Business Daily
Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report
July 06, 2022
Via
Benzinga
AstraZeneca's COVID-19 Treatment Allowed In China's Southern City: Reuters
July 06, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
July 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Mus's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5
July 05, 2022
Reuters
Via
Benzinga
AstraZeneca Strengthens Its Hematological Cancer Pipeline With TeneoTwo Acquisition
July 05, 2022
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire<
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.